Skip to main content
Top
Published in: Polymer Bulletin 12/2020

18-12-2019 | Original Paper

Preparation and evaluation of pharmaceutical co-crystals for solubility enhancement of atorvastatin calcium

Authors: Afreen Naqvi, Mahmood Ahmad, Muhmmad Usman Minhas, Kifayat Ullah Khan, Fakhra Batool, Ali Rizwan

Published in: Polymer Bulletin | Issue 12/2020

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

Co-crystallization is one of the methods to enhance the solubility of hydrophobic drugs that belong to BCS class II. Preparation and characterization of atorvastatin calcium co-crystals by liquid-assisted grinding method using citric acid and nicotinamide as co-formers for solubility enhancement were the objective of the current research. All the prepared formulations were characterized by powder X-ray diffraction (PXRD), Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), differential scanning calorimetry (DSC), scanning electron microscopy (SEM), zeta size analysis, dissolution and solubility studies. Solubility studies were performed in distilled water, pH 1.2 and pH 6.8. PXRD revealed the structural nature of the co-crystals formulations. FTIR, TGA and DSC confirmed the complex formation and have better thermal stability than individual components. SEM images exhibited the prism-like crystals with irregular and rough surfaces. Zeta size analysis showed the small particle size having large surface area that facilitates to improve the solubility. Dissolution and solubility studies of the formulations confirmed that solubility enhanced several folds in all media as compared to the solubility of available market drug. From all these studies, it can be concluded that co-crystallization technique enhanced the solubility of atorvastatin calcium by using liquid-assisted grinding method.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Literature
1.
go back to reference Junghanns J-UA, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 3(3):295 Junghanns J-UA, Müller RH (2008) Nanocrystal technology, drug delivery and clinical applications. Int J Nanomed 3(3):295
2.
go back to reference Loh ZH, Samanta AK, Heng PWS (2015) Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci 10(4):255–274CrossRef Loh ZH, Samanta AK, Heng PWS (2015) Overview of milling techniques for improving the solubility of poorly water-soluble drugs. Asian J Pharm Sci 10(4):255–274CrossRef
3.
go back to reference Kumar A et al (2011) Review on solubility enhancement techniques for hydrophobic drugs. Pharmacie Globale 3(3):001–007 Kumar A et al (2011) Review on solubility enhancement techniques for hydrophobic drugs. Pharmacie Globale 3(3):001–007
4.
go back to reference Vemula VR, Lagishetty V, Lingala S (2010) Solubility enhancement techniques. Int J Pharm Sci Rev Res 5(1):41–51 Vemula VR, Lagishetty V, Lingala S (2010) Solubility enhancement techniques. Int J Pharm Sci Rev Res 5(1):41–51
5.
go back to reference Kim J-S et al (2008) Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process. Int J Pharm 359(1):211–219PubMedCrossRef Kim J-S et al (2008) Physicochemical properties and oral bioavailability of amorphous atorvastatin hemi-calcium using spray-drying and SAS process. Int J Pharm 359(1):211–219PubMedCrossRef
6.
go back to reference Chaudhary A et al (2012) Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: a recent review. J Adv Pharm Educ Res 2(1):32–67 Chaudhary A et al (2012) Enhancement of solubilization and bioavailability of poorly soluble drugs by physical and chemical modifications: a recent review. J Adv Pharm Educ Res 2(1):32–67
8.
go back to reference Williams HD et al (2013) Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65(1):315–499PubMedCrossRef Williams HD et al (2013) Strategies to address low drug solubility in discovery and development. Pharmacol Rev 65(1):315–499PubMedCrossRef
9.
go back to reference Shekhawat P, Pokharkar V (2017) Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm Sin B 7(3):260–280CrossRef Shekhawat P, Pokharkar V (2017) Understanding peroral absorption: regulatory aspects and contemporary approaches to tackling solubility and permeability hurdles. Acta Pharm Sin B 7(3):260–280CrossRef
10.
go back to reference Khadka P et al (2014) Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 9(6):304–316CrossRef Khadka P et al (2014) Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian J Pharm Sci 9(6):304–316CrossRef
11.
go back to reference Charoenchaitrakool M et al (2000) Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind Eng Chem Res 39(12):4794–4802CrossRef Charoenchaitrakool M et al (2000) Micronization by rapid expansion of supercritical solutions to enhance the dissolution rates of poorly water-soluble pharmaceuticals. Ind Eng Chem Res 39(12):4794–4802CrossRef
12.
go back to reference Kawabata Y et al (2011) Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 420(1):1–10PubMedCrossRef Kawabata Y et al (2011) Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications. Int J Pharm 420(1):1–10PubMedCrossRef
14.
go back to reference Arenas-García JI et al (2017) Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals. Eur J Pharm Sci 96:299–308PubMedCrossRef Arenas-García JI et al (2017) Interrelation of the dissolution behavior and solid-state features of acetazolamide cocrystals. Eur J Pharm Sci 96:299–308PubMedCrossRef
15.
go back to reference Setyawan D et al (2014) Preparation and characterization of artesunate–nicotinamide co-crystal by solvent evaporation and slurry method. Asian J Pharm Clin Res 7(1):62–65 Setyawan D et al (2014) Preparation and characterization of artesunate–nicotinamide co-crystal by solvent evaporation and slurry method. Asian J Pharm Clin Res 7(1):62–65
16.
go back to reference Zaini E et al (2010) Cocrystalline phase transformation of binary mixture of trimethoprim and sulfamethoxazole by slurry technique. Asian J Pharm Clin Res 3(4):26–29 Zaini E et al (2010) Cocrystalline phase transformation of binary mixture of trimethoprim and sulfamethoxazole by slurry technique. Asian J Pharm Clin Res 3(4):26–29
17.
go back to reference Grossjohann C et al (2012) Characterisation, solubility and intrinsic dissolution behaviour of benzamide: dibenzyl sulfoxide cocrystal. Int J Pharm 422(1):24–32PubMedCrossRef Grossjohann C et al (2012) Characterisation, solubility and intrinsic dissolution behaviour of benzamide: dibenzyl sulfoxide cocrystal. Int J Pharm 422(1):24–32PubMedCrossRef
18.
go back to reference Serrano DR et al (2016) Modelling and shadowgraph imaging of cocrystal dissolution and assessment of in vitro antimicrobial activity for sulfadimidine/4-aminosalicylic acid cocrystals. Eur J Pharm Sci 89:125–136PubMedCrossRef Serrano DR et al (2016) Modelling and shadowgraph imaging of cocrystal dissolution and assessment of in vitro antimicrobial activity for sulfadimidine/4-aminosalicylic acid cocrystals. Eur J Pharm Sci 89:125–136PubMedCrossRef
19.
go back to reference Bavishi DD, Borkhataria CH (2016) Spring and parachute: how cocrystals enhance solubility. Prog Cryst Growth Charact Mater 62(3):1–8CrossRef Bavishi DD, Borkhataria CH (2016) Spring and parachute: how cocrystals enhance solubility. Prog Cryst Growth Charact Mater 62(3):1–8CrossRef
20.
go back to reference Drozd KV et al (2017) Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: screening, crystal structures, thermochemical and solubility studies. Eur J Pharm Sci 99:228–239PubMedCrossRef Drozd KV et al (2017) Drug-drug cocrystals of antituberculous 4-aminosalicylic acid: screening, crystal structures, thermochemical and solubility studies. Eur J Pharm Sci 99:228–239PubMedCrossRef
21.
go back to reference Gozali D et al (2016) Virtual screening of coformers for atorvastatin co-crystallization and the characterizations of the co-crystals. Int J Pharm Sci Res 7(4):1450 Gozali D et al (2016) Virtual screening of coformers for atorvastatin co-crystallization and the characterizations of the co-crystals. Int J Pharm Sci Res 7(4):1450
22.
go back to reference Wicaksono Y, Wisudyaningsih B, Siswoyo TA (2017) Cocrystal of atorvastatin calcium–malonic acid, pp 75–78 Wicaksono Y, Wisudyaningsih B, Siswoyo TA (2017) Cocrystal of atorvastatin calcium–malonic acid, pp 75–78
23.
go back to reference Farajzadeh MA, Khorram P, Pazhohan A (2016) Simultaneous determination of atorvastatin and valsartan in human plasma by solid-based disperser liquid–liquid microextraction followed by high-performance liquid chromatography–diode array detection. J Chromatogr B 1017:62–69CrossRef Farajzadeh MA, Khorram P, Pazhohan A (2016) Simultaneous determination of atorvastatin and valsartan in human plasma by solid-based disperser liquid–liquid microextraction followed by high-performance liquid chromatography–diode array detection. J Chromatogr B 1017:62–69CrossRef
24.
go back to reference Ramani K et al (2012) Design and development of atorvastatin calcium buccoadhesive bilayered devices for oral drug delivery. J Drug Deliv Sci Technol 22(6):505–510CrossRef Ramani K et al (2012) Design and development of atorvastatin calcium buccoadhesive bilayered devices for oral drug delivery. J Drug Deliv Sci Technol 22(6):505–510CrossRef
25.
go back to reference Ahmed IS et al (2016) PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles. Int J Pharm 504(1):70–79PubMedCrossRef Ahmed IS et al (2016) PD-PK evaluation of freeze-dried atorvastatin calcium-loaded poly-ε-caprolactone nanoparticles. Int J Pharm 504(1):70–79PubMedCrossRef
26.
go back to reference Zhang H-X et al (2009) Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm 374(1):106–113PubMedCrossRef Zhang H-X et al (2009) Micronization of atorvastatin calcium by antisolvent precipitation process. Int J Pharm 374(1):106–113PubMedCrossRef
27.
go back to reference Kanoujia J et al (2016) Novel genipin crosslinked atorvastatin loaded sericin nanoparticles for their enhanced antihyperlipidemic activity. Mater Sci Eng, C 69:967–976CrossRef Kanoujia J et al (2016) Novel genipin crosslinked atorvastatin loaded sericin nanoparticles for their enhanced antihyperlipidemic activity. Mater Sci Eng, C 69:967–976CrossRef
28.
go back to reference Choudhary A et al (2012) Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharm Sin B 2(4):421–428CrossRef Choudhary A et al (2012) Development and characterization of an atorvastatin solid dispersion formulation using skimmed milk for improved oral bioavailability. Acta Pharm Sin B 2(4):421–428CrossRef
29.
go back to reference Mukaida M et al (2015) Identification and physicochemical characterization of caffeine–citric acid co-crystal polymorphs. Eur J Pharm Sci 79:61–66PubMedCrossRef Mukaida M et al (2015) Identification and physicochemical characterization of caffeine–citric acid co-crystal polymorphs. Eur J Pharm Sci 79:61–66PubMedCrossRef
30.
go back to reference Ganesh M et al (2015) Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac. Int J Biol Macromol 74:310–317PubMedCrossRef Ganesh M et al (2015) Chitosan cocrystals embedded alginate beads for enhancing the solubility and bioavailability of aceclofenac. Int J Biol Macromol 74:310–317PubMedCrossRef
31.
go back to reference Cugovčan M et al (2017) Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding. J Pharm Biomed Anal 137:42–53PubMedCrossRef Cugovčan M et al (2017) Biopharmaceutical characterization of praziquantel cocrystals and cyclodextrin complexes prepared by grinding. J Pharm Biomed Anal 137:42–53PubMedCrossRef
32.
go back to reference Hsu P-C et al (2012) Solid-state thermal behavior and stability studies of theophylline–citric acid cocrystals prepared by neat cogrinding or thermal treatment. J Solid State Chem 192:238–245CrossRef Hsu P-C et al (2012) Solid-state thermal behavior and stability studies of theophylline–citric acid cocrystals prepared by neat cogrinding or thermal treatment. J Solid State Chem 192:238–245CrossRef
33.
34.
go back to reference Shimono K et al (2015) Kinetics of co-crystal formation with caffeine and citric acid via liquid-assisted grinding analyzed using the distinct element method. Eur J Pharm Sci 76:217–224PubMedCrossRef Shimono K et al (2015) Kinetics of co-crystal formation with caffeine and citric acid via liquid-assisted grinding analyzed using the distinct element method. Eur J Pharm Sci 76:217–224PubMedCrossRef
35.
go back to reference Tomaszewska I et al (2013) Pharmaceutical characterisation and evaluation of cocrystals: importance of in vitro dissolution conditions and type of coformer. Int J Pharm 453(2):380–388PubMedCrossRef Tomaszewska I et al (2013) Pharmaceutical characterisation and evaluation of cocrystals: importance of in vitro dissolution conditions and type of coformer. Int J Pharm 453(2):380–388PubMedCrossRef
Metadata
Title
Preparation and evaluation of pharmaceutical co-crystals for solubility enhancement of atorvastatin calcium
Authors
Afreen Naqvi
Mahmood Ahmad
Muhmmad Usman Minhas
Kifayat Ullah Khan
Fakhra Batool
Ali Rizwan
Publication date
18-12-2019
Publisher
Springer Berlin Heidelberg
Published in
Polymer Bulletin / Issue 12/2020
Print ISSN: 0170-0839
Electronic ISSN: 1436-2449
DOI
https://doi.org/10.1007/s00289-019-02997-4

Other articles of this Issue 12/2020

Polymer Bulletin 12/2020 Go to the issue

Premium Partners